Title: A CXCR2-specific monoclonal antibody alleviates excessive neutrophil syndromes in preclinical models of inflammation
Disease and Therapeutics · 2026 · 3 · 100020
DOI: 10.1016/j.dist.2026.100020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease and Therapeutics, 2026. Verfasst von Tao Wang und 14 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Eye Institute, Lowy Medical Research Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Eye Institute
- Lowy Medical Research Institute
Zitieren
APA
Wang, T., Wei, G., Shen, J., Shen, Y., Cheng, Z., Wang, F., Dong, X., Yan, L., Dong, L., Chen, X., Wan, Y., Usui-Ouchi, A., Friedlander, M., Yang, G., & Shi, X. (2026). Title: A CXCR2-specific monoclonal antibody alleviates excessive neutrophil syndromes in preclinical models of inflammation. Disease and Therapeutics, 3, 100020. https://doi.org/10.1016/j.dist.2026.100020
Vancouver
Wang T, Wei G, Shen J, Shen Y, Cheng Z, Wang F, et al. Title: A CXCR2-specific monoclonal antibody alleviates excessive neutrophil syndromes in preclinical models of inflammation. Disease and Therapeutics. 2026;3:100020. doi:10.1016/j.dist.2026.100020
BibTeX
@article{Wang2026,
author = {Wang, Tao and Wei, Guoqin and Shen, Jinling and Shen, Yunyue and Cheng, Zelin and Wang, Fei and Dong, Xuxue and Yan, Lei and Dong, Liang and Chen, Xixi and Wan, Yue and Usui-Ouchi, Ayumi and Friedlander, Martin and Yang, Guang and Shi, Xiaojie},
title = {Title: A CXCR2-specific monoclonal antibody alleviates excessive neutrophil syndromes in preclinical models of inflammation},
journal = {Disease and Therapeutics},
year = {2026},
volume = {3},
pages = {100020},
doi = {10.1016/j.dist.2026.100020}
}
EUVIMED